This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Bahat G, Ilhan B, Karan MA. Comment on “Pharmacological management of osteoporosis in rheumatoid arthritis patients: a review of the literature and practical guide”. Drugs Aging. 2020. https://doi.org/10.1007/s40266-020-00751-4.
Raterman HG, Lems WF. Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide. Drugs Aging. 2019;36(12):1061–72. https://doi.org/10.1007/s40266-019-00714-4.
Buckley L, Humphrey MB. Glucocorticoid-Induced Osteoporosis. N Engl J Med. 2018;379(26):2547–56. https://doi.org/10.1056/NEJMcp1800214.
No funding was received for the preparation of this letter.
Conflicts of interest
Hennie G. Raterman has received an unrestricted educational grant from UCB, and consulting fees from Amgen, Cellgene and Sanof Genzyme. Willem F. Lems has received a grant from Pfzer, and consulting fees from MSD, Amgen, Lilly, Pfzer and UCB.
About this article
Cite this article
Raterman, H.G., Lems, W.F. Authors’ Reply to Comment on “Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide”. Drugs Aging 37, 239–240 (2020). https://doi.org/10.1007/s40266-020-00751-4